This study assessed the diagnostic value of the cytomegalovirus (CMV)-specific IgG avidity index (AI) for pregnant women without a history of CMV seroconversion. Sera were studied from 40 women with CMV seroconversion (group I), 70 with past CMV infection (group II), 10 (20 sera) with serologic reactivation (group III), and 41 with CMV-specific IgM without proven seroconversion (group IV). Sera from women in group I collected õ14 weeks after seroconversion had a low AI (mean, 30% { 12%), whereas all sera from women in group II had an AI ú60% (mean, 88% { 9%). Among the 41 babies born to group IV women, only 4 were infected with CMV (all born to mothers with a low [õ30%] AI early in pregnancy). These results suggest that AI determination may help to date a primary CMV infection in pregnant women who lack seroconversion history. in the study. Sera from pregnant women were sent from 1992 to Accurate diagnosis of cytomegalovirus (CMV) primary in- in pregnant women.
fection in pregnant women is important, since CMV is the most for diagnosis of primary CMV infection in women considered at common cause of congenital infection in humans [1] . While risk (Clamart, Geneva).
the presence of antibodies to CMV in sera of previously seroFour groups of pregnant women were studied. Group I, 40 negative subjects remains a reliable means for diagnosis of women with well-documented CMV seroconversion, had 87 postprimary CMV infection, it is usually practical only for closely seroconversion samples (1-8 samples/woman). Of the samples, monitored patients (e.g., transplant recipients, for whom pre-68 were obtained õ14 weeks (3 months) after the last seronegative and postinfection sera are readily available) [2] . CMV-specific sample, and 19 were obtained §14 weeks after that date. Group IgM has been proposed as a means for identifying primary II comprised 70 women with serologic evidence of prior CMV infection (presence of CMV-specific IgG, absence of CMV-speinfection. However, a CMV-specific IgM response is frequently tides may distinguish primary from secondary CMV infection Sixty-six fetuses and infants were tested for CMV infection (25 [3] , but commercial kits for this purpose are not yet available born to group I mothers and 41 to group IV mothers). and the procedure is time-consuming. Using the urea denaturAntibody detection. Serum samples were tested for CMV IgG ation procedure first described for rubella [4] , Blackburn et al.
by commercial indirect enzyme immunoassays (Enzygnost-CMV IgG: Behring, Marburg, Germany; IgG MEIA: Abbott Labora- [5] showed that measurement of CMV-specific IgG avidity tories, Abbott Park, IL) and for CMV IgM by capture immunoassay could help in diagnosing recent primary CMV infection. We in pregnant women.
Avidity of IgG. For CMV-specific IgG avidity, sera were measured by the Enzygnost-CMV IgG kit according to the manufactur-
Materials and Methods
er's recommendations, except for the wash step after the first antiStudy population. Three French laboratories (in Caen, Clabody incubation, when 8 M urea was added in parallel with PBSmart, and Paris) and one Swiss laboratory (Geneva) participated Tween 20, as previously described [4] . The AI was expressed as follows: Percentage of AI Å (absorbance result of CMV per well with urea wash/absorbance result of CMV per well without urea SD and the range. When measurements for the same woman were 53%). The intervals between the last seronegative and the first done at two different time points, we made paired comparisons of seropositive samples were 6.5 { 3.4 and 6.6 { 3.7 weeks, the mean percentages. All probability values are two-tailed. The respectively.
threshold of significance was set at .05.
In the 10 cases of reactivation (group III), the mean AIs before and after reactivation were 83% { 7% (range, 72%-97%) and 92% { 6% (range, 76%-100%), respectively. The Results mean difference in AIs between these 2 serum samples was For the 40 women with well-documented seroconversion significantly different from 0 (8% { 5%; P õ .01). (group I), 87 sera were obtained after the last seronegative Among the 41 serum samples obtained during the first trisample. Among these 87 samples, 68 were obtained õ14 weeks mester of pregnancy from women who lacked well-documented (3 months) after the last seronegative sample. The mean CMV seroconversion (group IV), 5 had AIs £30% (group IVa), 14 IgG AI of the first sample was 30% { 12% (range, 8%-58%).
had AIs of 40%-70% (group IVb), and 22 had AIs ú70% For the 70 pregnant women with a past CMV infection (group (group IVc). All pregnancy outcomes were known for these II), the mean AI was significantly higher (88% { 9%; range, 41 women. Four babies were infected with CMV, all born to 60%-100%; P õ .001) than the mean of the first positive women with low AIs (£30%, group IVa). sample for women in group I. In the latter group, we observed an increase in AI with time in all serial serum specimens. Figure 1 shows the temporal changes in IgG avidity for the 12 Discussion women for whom ú2 positive samples were available. Of the 68 sera obtained õ14 weeks after the negative sample, only 6 Since the overall incidence of symptomatic congenital CMV is low (Ç0.05%) [1] and risk factors are not well defined, it had a CMV IgG AI ú50% (maximum value, 65%), and 2 of 19 samples obtained after 14 weeks had an AI õ50% (43% has been difficult to develop strategies for detection of CMV infection, especially for asymptomatic primary infection in and 44%). Only 7 women in group I had serum samples available that were positive õ3 months after the last seronegative pregnant women. Some obstetricians propose CMV testing of all pregnant women; others screen for CMV antibody only in sample and a sample obtained §14 weeks later. The mean difference in AIs between these two categories of sera was women considered at risk (e.g., pediatric nurses, teachers, day care workers). Thus, CMV IgM is sometimes detected in the significantly different from 0 (33% { 22%; P õ .01).
For 25 group I women whose pregnancy outcome was serum of an asymptomatic pregnant woman whose immune status before conception is not known, which raises issues known, 12 fetuses or infants were infected. The mean AI of the first positive sample of women who transmitted virus was about interpretation of results. For a variety of viral infections, including rubella, varicella-zoster, human herpesvirus, hepatitis 30.3% { 9.2% (range, 15.5%-43%), not significantly different from that of nontransmitters (33.2% { 13.8%; range, 8%-C [4, [8] [9] [10] [11] [12] , and more recently CMV [5, 13] , the usefulness
